2016 Drug Development Vaccines 
pharmaphorum
SEPTEMBER 27, 2021
As the vaccines were developed and rolled out, the disparity in their take up among different sections of the community highlighted how excluded some minority communities felt from areas of healthcare. In 2016, the pharmaceutical industry was found to have less gender and ethnic diversity than other industries in the Fortune 500.
pharmaphorum
APRIL 11, 2022
Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. Delivering value for patients doesn’t start and end in our R&D labs; actions can be implemented across all stages of the drug development lifecycle to encourage and embrace a pro-innovation environment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 20, 2022
Monitoring and studying the side effects of licensed medicines is an essential part of drug development to ensure public safety. Known as pharmacovigilance, our epidemiological research records and investigates adverse drug reactions when medicines are used by the general public. Supporting regulators. Study focus.
PharmaShots
MARCH 14, 2023
The article focuses on challenges faced in drug development, government incentive programs, grants, and various therapies used to diagnose or treat rare diseases. How challenging is the drug development plan Drug development plans for rare diseases can be circuitous, resulting in fewer participation from companies.
Putting Patients First Blog
APRIL 30, 2024
Assessment of length and readability of informed consent documents for COVID-19 vaccine trials. A blueprint for developing patient-centered core impact sets (PC-CIS). Re: Patient-Focused Drug Development: Guidance 1 – Collecting Comprehensive and Representative Input; Public Workshop (Docket No. and Boyle, C. and Argo, N.
pharmaphorum
SEPTEMBER 18, 2020
However, it withdrew its neuropharmacological drug, Zelmid, which was an SSRI, due to concerns over side effects only a year after it was introduced in 1982. In 1990, the US Food and Drug Administration (FDA) requested Astra to change Losec’s brand name to Prilosec, to avoid confusion with Sanofi-Aventis’ diuretic, Lasix (furosemide).
PharmaShots
JANUARY 31, 2023
Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Founded Year: 2016 No. With an aim to develop a VLP-based vaccine candidate, Frazier and Takeda Pharmaceuticals underwent a collaboration to form Hillevax.
Expert insights. Personalized for you.
122 
Let's personalize your content